Nashville Veterans Affairs Medical Center, Vanderbilt University School of Medicine, Nashville, Tennessee; Section of Surgical Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Epithelial Biology Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas; Department of Medicine, Baylor College of Medicine, Houston, Texas; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Gastroenterology. 2022 Feb;162(2):415-430. doi: 10.1053/j.gastro.2021.10.036. Epub 2021 Oct 30.
The mucosa of the body of the stomach (ie, the gastric corpus) uses 2 overlapping, depth-dependent mechanisms to respond to injury. Superficial injury heals via surface cells with histopathologic changes like foveolar hyperplasia. Deeper, usually chronic, injury/inflammation, most frequently induced by the carcinogenic bacteria Helicobacter pylori, elicits glandular histopathologic alterations, initially manifesting as pyloric (also known as pseudopyloric) metaplasia. In this pyloric metaplasia, corpus glands become antrum (pylorus)-like with loss of acid-secreting parietal cells (atrophic gastritis), expansion of foveolar cells, and reprogramming of digestive enzyme-secreting chief cells into deep antral gland-like mucous cells. After acute parietal cell loss, chief cells can reprogram through an orderly stepwise progression (paligenosis) initiated by interleukin-13-secreting innate lymphoid cells (ILC2s). First, massive lysosomal activation helps mitigate reactive oxygen species and remove damaged organelles. Second, mucus and wound-healing proteins (eg, TFF2) and other transcriptional alterations are induced, at which point the reprogrammed chief cells are recognized as mucus-secreting spasmolytic polypeptide-expressing metaplasia cells. In chronic severe injury, glands with pyloric metaplasia can harbor both actively proliferating spasmolytic polypeptide-expressing metaplasia cells and eventually intestine-like cells. Gastric glands with such lineage confusion (mixed incomplete intestinal metaplasia and proliferative spasmolytic polypeptide-expressing metaplasia) may be at particular risk for progression to dysplasia and cancer. A pyloric-like pattern of metaplasia after injury also occurs in other gastrointestinal organs including esophagus, pancreas, and intestines, and the paligenosis program itself seems broadly conserved across tissues and species. Here we discuss aspects of metaplasia in stomach, incorporating data derived from animal models and work on human cells and tissues in correlation with diagnostic and clinical implications.
胃体的黏膜(即胃底)使用 2 种重叠的、深度依赖的机制来应对损伤。浅表损伤通过具有组织病理学变化(如滤泡增生)的表面细胞愈合。较深的、通常为慢性的损伤/炎症,最常由致癌细菌幽门螺杆菌引起,会引起腺体的组织病理学改变,最初表现为幽门(也称为假幽门)化生。在这种幽门化生中,胃底腺变成类似于胃窦(幽门)的结构,壁细胞(即分泌胃酸的细胞)丢失(萎缩性胃炎),滤泡细胞扩张,消化酶分泌的主细胞重新编程为深的胃窦样粘液细胞。在壁细胞急性丢失后,主细胞可以通过白细胞介素 13 分泌的固有淋巴细胞(ILC2)启动的有序逐步进展(返老还童)进行重新编程。首先,大量溶酶体激活有助于减轻活性氧和清除受损的细胞器。其次,诱导粘液和伤口愈合蛋白(如 TFF2)和其他转录改变,此时,重新编程的主细胞被识别为分泌粘液的收缩多肽表达化生细胞。在慢性严重损伤中,具有幽门化生的腺体可以同时含有活跃增殖的收缩多肽表达化生细胞,最终还可能含有肠型细胞。具有这种谱系紊乱(混合不完全肠化生和增殖收缩多肽表达化生)的胃腺可能特别容易发生异型增生和癌症。损伤后也会在其他胃肠道器官(包括食管、胰腺和肠道)中出现类似幽门的化生模式,并且返老还童程序本身似乎在组织和物种之间广泛保守。本文我们将讨论胃化生的各个方面,整合来自动物模型的数据以及人类细胞和组织的研究结果,并与诊断和临床意义相关联。